Uploaded via media manager.

Texas, including Austin, is leading the way in COVID-19 research

Recently, the Texas Tribune and KEYE-News, reported that Texas has emerged as a leading site for COVID-19 research, both in the search for a vaccine and for treatments for active cases.

Currently, the state is the site of 130 clinical trials investigating possible vaccines and treatments for the coronavirus, because Texas is home to massive research universities, hundreds of hospitals and unfortunately, a relatively high rate of coronavirus transmission. That’s the most trials of any state other than California and New York, according to the National Institutes of Health.

Austin Regional Clinic vaccine trial

Austin is among the other major Texas cities involved in this research; ARC Clinical Research has been running a COVID-19 vaccine clinical trial since early August. Leaders of vaccine clinical trials say they’ve seen unprecedented numbers of people asking to sign up. “It’s a commonality of really almost all research participants is that they’re doing it for purposes of trying to be helpful, helpful for people in the future even if they think this may not be helpful for themselves,” said Dr. Gretchen Crook, the principal investigator of clinical research at Austin Regional Clinic at ARC Wilson Parke, which is running a double-blind clinical trial with the Pfizer/BioNTech vaccine candidate.

As of mid-September, the clinic had enrolled about 150 participants in its clinical trial and aimed to sign up about 100 more.

“Almost everybody that comes in has this view that this is a really unique opportunity to make a difference in the world, something that they have felt helpless for the last several months watching this catastrophe unfold,” Dr. Crook said.

Learn more about current ARC Clinical Research trials.

Tags: ARC Clinical Research, COVID-19, ARC COVID-19 Care

More on this Topic

ARC Clinical Research contributes to COVID-19 Vaccine Trial

ARC Clinical Research is excited to announce its participation in a prominent COVID-19 vaccine clinical trial that will begin in early August 2020.  ARC will recruit 250 ARC patients from across Central Texas to enroll in this late phase clinical trial. If you are interested in enrolling, please request to participate at ARCclinicalresearch.com or call 512-225-5931.

Protecting our children’s mental health during the COVID-19 pandemic

The COVID-19 pandemic is having a profoundly negative impact on the mental health of some of our children, leading to anxiety and depression. Dr. James Anderson addresses what to watch for and how you can help your child.

Leading local medical experts share how to stay healthy during a pandemic

Dr. Jay R. Zdunek, Chief Medical Officer (CMO) of Austin Regional Clinic, along with other Austin area hospital CMOs, recently answered questions and addressed concerns about best practices on seeking healthcare during the COVID-19 pandemic during an Austin Chamber webinar.

ARC COVID-19 vaccine trial to continue on schedule

In response to announcements of the possible release of a COVID-19 vaccine as early as October 2020, ARC has said it will continue its vaccine trial. Dr. Anas Daghestani, CEO of ARC has said, “Our timeline is still the same.”

ARC is now offering an in-house COVID-19 test

Austin Regional Clinc is now offering a COVID-19 test with a 1-2 day turnaround time to new and existing patients. The test is available at most ARC clinics as well at our Drive-Up/Curbside test sites.